GlassScriptPhysician profile
Anil Shetty
NPI 1215058359
$5,740.22
in general payments reported to CMS, 2019-2025
16 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what 86% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $207 · 2021: $153 · 2022: $128 · 2023: $1,378 · 2024: $677 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,847 · Consulting Fee: $1,588 · Honoraria: $975 · Long Term Medical Supply Or Device Loan: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,846.81 |
| Consulting Fee | $1,587.50 |
| Honoraria | $975.00 |
| Long Term Medical Supply Or Device Loan | $181.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $975.00 | 2025 | |
| Solventum Corporation | $800.00 | 2025 | Abthera, Prevena, V.A.C. Veraflo Cleanse Choice |
| Kci USA, INC. | $787.50 | 2023 | Prevena, Prevena Restor Bellaform, V.A.C. Veraflo |
| Allergan, INC. | $664.81 | 2019-2022 | |
| Kerecis Limited | $642.87 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Abbvie INC. | $541.48 | 2023-2025 | Revolve, Natrelle Saline-Filled Breast Implants |
| Tela Bio, INC. | $422.55 | 2019-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $288.15 | 2023-2024 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Integra Lifesciences Corporation | $181.16 | 2025 | Integra |
| Acera Surgical, INC. | $159.37 | 2023 | Restrata Wound Matrix |
| Polynovo North America LLC | $121.57 | 2024 | Novosorb Btm |
| Access Pro Medical, LLC | $72.30 | 2025 | Matriderm |
| Regeneron Healthcare Solutions, INC. | $33.00 | 2025 | Libtayo |
| Smith+Nephew, INC. | $20.57 | 2024 | Grafix, Stravix Mesh, Oasis |
| Celgene Corporation | $17.33 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Shetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.